Showing results (301-310 of 345) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary AdenomasFederico Gatto, Richard A Feelders, Sanne E Franck, et al.
Biotechnology Advances|August 30, 2011
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cellsGiovanni Vitale, Silvia Zappavigna, Monica Marra, et al.
European Journal of Endocrinology|July 25, 2009
Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetesRosalie M Kiewiet, Maarten O van Aken, Kim van der Weerd, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitroLeo J Hofland, Joost van der Hoek, Peter M van Koetsveld, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patientsJoost van der Hoek, Wouter W de Herder, Richard A Feelders, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
Somatostatin receptors in malignant lymphomas: targets for radiotherapy?Virgil A S H Dalm, Leo J Hofland, Cornelia M Mooy, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 12, 2002
Quantitative and functional expression of somatostatin receptor subtypes in human thymocytesDiego Ferone, Rosario Pivonello, P Martin Van Hagen, et al.
Cancer Research|February 11, 1998
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapyM de Jong, W A Breeman, W H Bakker, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2009
Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomasChristiaan de Bruin, Alberto M Pereira, Richard A Feelders, et al.
Pageof 35